Rx Numelvi (atinvicitinib) Tablets for Dogs with Allergic Dermatitis

Rx Numelvi (atinvicitinib tablets) for Dogs

Rx Numelvi (atinvicitinib tablets) is a once-daily prescription medication formulated to help control itching associated with allergic dermatitis in dogs 6 months of age and older. As a second-generation Janus kinase (JAK) inhibitor, Numelvi works by targeting itch and inflammation pathways linked to allergic skin conditions, helping provide fast and effective itch relief for dogs suffering from environmental, flea, food, or contact allergies.

Numelvi begins reducing itch within approximately 2 to 4 hours, with studies showing significant improvement in itching within the first week of treatment. Safe for dogs and puppies weighing at least 2 kg, this convenient once-daily oral tablet helps simplify allergy management for pets, owners, and veterinarians alike.

Features:

• Helps control itching associated with allergic dermatitis in dogs
• Second-generation JAK inhibitor containing atinvicitinib
• Starts reducing itch within approximately 2 to 4 hours
• Significant itch improvement may be seen within 1 week
• Convenient once-daily oral dosing
• For dogs and puppies 6 months of age and older
• Can be used in dogs weighing at least 2 kg
• May be used for environmental, flea, food, and contact-related allergic dermatitis
• Designed to help simplify long-term allergy management

Directions:

Administer orally once daily as directed by your veterinarian at a dose of 0.36 to 0.54 mg atinvicitinib/lb (0.8 to 1.2 mg/kg) of body weight. NUMELVI should be given with food. Always follow your veterinarian’s dosing instructions for your specific dog.

Ingredients:

Atinvicitinib

Storage:

Store at room temperature between 59°F and 86°F.

Cautions and Warnings:

Use only as directed by a licensed veterinarian. Keep out of reach of children.

Possible Side Effects:

Possible adverse reactions may include vomiting, nausea, diarrhea, decreased appetite, lethargy, otitis externa, bacterial skin infections, urinary tract infections, crystalluria, or hematuria without urinary tract infection. Dogs should be monitored for signs of infection, as NUMELVI may increase susceptibility to opportunistic infections including demodicosis and interdigital furunculosis. Contact your veterinarian if unusual symptoms occur.

Precautions:

The safety and effectiveness of NUMELVI beyond 28 days have not been fully evaluated in field studies. Safe use has not been established in breeding, pregnant, or lactating dogs. Decreased mean testes weight was observed in laboratory safety studies. The safety of concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been evaluated.

This product requires a Valid prescription.

All prescription items are Non-Refundable and Non-Returnable.